Sponsors of Europe AF 2017

The organisers would like to thank the following companies for their support of EUROPE AF 2017:


DIAMOND

 
Visit the website
As a global leader in medical technology, services and solutions, Medtronic improves the lives and health of millions of people each year. We use our deep clinical, therapeutic, and economic expertise to address the complex challenges faced by healthcare systems today. We are committed to partnering in new ways and developing powerful solutions that deliver better patient outcomes.

Founded in 1949 as a medical repair company, we are now among the world's largest medical technology, services and solutions companies, employing more than 85,000 people worldwide, serving physicians, hospitals and patients in nearly 160 countries.

The Arctic Front Advance Cryoablation system is establishing a new Gold Standard for AF ablation.

Let’s take healthcare Further, Together. Learn more at afsolutions.eu or medtronic.eu
 

PLATINUM

Sponsors of 'EVOLVING APPROACHES TO STROKE PREVENTION PART 1' on Day 1 at 11:45


Visit the website
Bayer: Science For A Better Life

Bayer is a global enterprise with core competencies in the Life Science fields of healthcare and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2015, the Group employed around 117,000 people and had sales of EUR 46.3 billion. Capital expenditures amounted to EUR 2.6 billion, R&D expenses to EUR 4.3 billion. These figures include those for the high-tech polymers business, which was floated on the stock market as an independent company named Covestro on October 6, 2015. For more information, go to www.bayer.com.

SILVER

Sponsors of Satellite Symposium on Day 1 at 17:35
 
Visit the website
Acutus Medical® will transform the lives of millions of patients by providing electrophysiologists the groundbreaking technology to fully visualize activation patterns of every heartbeat. The AcQMap® System enables ElectroFunctional™ procedures for real-time, non-contact, dipole density mapping to guide patient-specific ablation strategies for complex arrhythmias and confirming by remapping in seconds.
 
Visit the website
The Daiichi Sankyo Group is dedicated to the creation and supply of innovative pharmaceutical products to address diversified, unmet medical needs of patients in both mature and emerging markets. With over 100 years of scientific expertise and a presence in more than 20 countries, Daiichi Sankyo and its 16,000 employees around the world draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help people.

In addition to its strong portfolio of medicines for hypertension, dyslipidemia, bacterial infections, and thrombotic disorders, the Group’s research and development is focused on bringing forth novel therapies in cardiovascular-metabolic diseases, pain management, and oncology, including biologics. Daiichi Sankyo’s European base is located in Munich and has affiliates in 12 European countries in addition to a global manufacturing site located in Pfaffenhofen, Germany. For more information, please visit: www.daiichi-sankyo.eu
 

BRONZE
 
  
 
Visit the website
CardioFocus is a medical device innovator and manufacturer dedicated to advancing ablation treatment for cardiac disorders such as atrial fibrillation (AF). The company’s HeartLight Endoscopic Ablation System is a revolutionary catheter ablation technology designed for the treatment of AF, the most common heart arrhythmia. The HeartLight System's direct visualization, titratable laser energy, and universal balloon design make it a new standard for pulmonary vein isolation (PVI) procedures. The HeartLight System is approved for use and commercially available in the United States and Europe. More than 4,000 patients with AF have been successfully treated with the system. For more information on the company and its technology, please visit: www.cardiofocus.com 
 
 
Visit the website 
Baylis Medical develops and markets high-technology medical devices used in the fields of interventional cardiology and interventional radiology. Our vision is to develop and market innovative medical therapies while Improving the Lives of People Around the World. Company has offices in Montreal and Toronto (Canada), Boston (USA), and London (UK). 
 

 OTHER SUPPORTERS
 
    

   Visit the website

For details of exhibition and sponsorship opportunities please contact the organising secretariat Millbrook Medical Conferences at europeaf@millbrookconferences.co.uk

©2017 Millbrook Medical Conferences.
All Rights Reserved. Industry | Disclaimer
Website design by ZARR Ltd
T: +44 (0) 1455 552559
F: +44 (0) 1455 557377
E: EuropeAF@millbrookconferences.co.uk
Millbrook Medical Conferences Ltd,
Unit 8, Midland Court, Central Park,
Lutterworth, LE17 4PN, UK